Post-Market Study of Transbronchial Cryo-assisted RFA During Robotic Bronchoscopy With Subsequent Surgical Resection

Critères d'exclusion

• Pregnant or nursing (breast feeding) females • Central tumors abutting vital structures (main bronchus, pulmonary artery, esophagus, trachea) • Thoracic electronic implants (e.g., pacemakers, ICDs) • Uncorrectable coagulopathy or platelet count ≤ 50,000/mm³ • Patients receiving anticoagulant therapy or with pulmonary hypertension that, in the opinion of the Investigator, poses an unacceptable safety risk for bronchoscopy and ablation. • Severe, uncontrolled comorbidities • Active systemic infection • Prior radiation therapy (SBRT) in the intended ablation zone • Recent Investigational therapy within the last 30 days that the investigator deems could interfere with proceeding in the clinical investigation • Tumors associated with atelectasis, obstructive pneumonitis, pleural effusion, or fibrosis • Investigators determine that study participation poses safety risk • Any comorbidities judged by the principal Investigator to be contraindicated for bronchoscopy • Subject was judged unsuitable for study participation by the Investigator for any other reason